A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Clinical trial NCT00441337 · COMPLETED

Trial details

NCT number: NCT00441337
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Colorectal Cancer Malignant Melanoma Renal Cancer Prostate Cancer

Start date: 2006-08-01
Primary completion: 2009-11-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.